Computational analysis of the LRRK2 interactome

PeerJ
Claudia ManzoniPatrick A Lewis

Abstract

LRRK2 was identified in 2004 as the causative protein product of the Parkinson's disease locus designated PARK8. In the decade since then, genetic studies have revealed at least 6 dominant mutations in LRRK2 linked to Parkinson's disease, alongside one associated with cancer. It is now well established that coding changes in LRRK2 are one of the most common causes of Parkinson's. Genome-wide association studies (GWAs) have, more recently, reported single nucleotide polymorphisms (SNPs) around the LRRK2 locus to be associated with risk of developing sporadic Parkinson's disease and inflammatory bowel disorder. The functional research that has followed these genetic breakthroughs has generated an extensive literature regarding LRRK2 pathophysiology; however, there is still no consensus as to the biological function of LRRK2. To provide insight into the aspects of cell biology that are consistently related to LRRK2 activity, we analysed the plethora of candidate LRRK2 interactors available through the BioGRID and IntAct data repositories. We then performed GO terms enrichment for the LRRK2 interactome. We found that, in two different enrichment portals, the LRRK2 interactome was associated with terms referring to transport, cellul...Continue Reading

References

Mar 7, 2003·Genome Biology·Bobby-Joe BreitkreutzMike Tyers
Dec 19, 2003·Nucleic Acids Research·Henning HermjakobRolf Apweiler
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Jun 28, 2005·Nucleic Acids Research·Bing ZhangJay Snoddy
Dec 6, 2006·Nucleic Acids Research·S KerrienH Hermjakob
May 1, 2009·Human Genomics·Benjamin Lehne, Thomas Schlitt
Dec 19, 2009·The New England Journal of Medicine·Fu-Ren ZhangJian-Jun Liu
Apr 21, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Sabrina ZechelOliver von Bohlen Und Halbach
Aug 24, 2010·Journal of Neuroimmunology·Makoto KuboFumiya Obata
Sep 8, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Rachel Saunders-PullmanSusan B Bressman
Jul 9, 2011·PLoS Genetics·UNKNOWN International Parkinson's Disease Genomics Consortium (IPDGC), UNKNOWN Wellcome Trust Case Control Consortium 2 (WTCCC2)
Oct 21, 2011·Human Molecular Genetics·Patricia Gómez-SuagaSabine Hilfiker
Jan 19, 2012·Science Signaling·Patrick A Lewis, Claudia Manzoni
Feb 4, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mark S MoehleAndrew B West
Mar 29, 2012·Nature Methods·Sandra OrchardHenning Hermjakob
May 23, 2012·Proteomics·Sandra Orchard
Nov 8, 2012·Nature Methods·Rintaro SaitoTrey Ideker
Dec 4, 2012·Nucleic Acids Research·Andrew Chatr-AryamontriMike Tyers
May 16, 2013·PloS One·Florian GiesertWolfgang Wurst
May 25, 2013·Nucleic Acids Research·Jing WangBing Zhang
Aug 7, 2013·Biochimica Et Biophysica Acta·Claudia ManzoniPatrick A Lewis
Aug 14, 2013·Journal of Parkinson's Disease·Coro Paisán-RuizAndrew B Singleton
Dec 21, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Javier Ruiz-MartínezJosé F Martí Massó
Apr 1, 2014·Human Molecular Genetics·Jason SchapanskyMatthew J LaVoie

❮ Previous
Next ❯

Citations

Jan 31, 2016·Neuroinformatics·R E FoulgerR C Lovering
Apr 23, 2015·The FEBS Journal·Rebecca WallingsRina Bandopadhyay
May 27, 2015·Current Neurology and Neuroscience Reports·Mark R Cookson
Jul 17, 2016·Proceedings of the National Academy of Sciences of the United States of America·Mark R Cookson
Oct 13, 2016·Scientific Reports·Claudia ManzoniPatrick A Lewis
Jun 14, 2017·Expert Opinion on Therapeutic Targets·Susanna CogoPatrick A Lewis
Nov 25, 2016·Briefings in Bioinformatics·Claudia ManzoniRaffaele Ferrari
Jan 9, 2018·Cell and Tissue Research·Alice PricePatrick A Lewis
Nov 24, 2018·Biochemical Society Transactions·Laura CivieroElisa Greggio
May 28, 2019·The Journal of Physiology·Patrick A Lewis
May 24, 2018·The EMBO Journal·Anetta HärtlovaMaximiliano G Gutierrez
Feb 17, 2017·Biochemical Society Transactions·Claudia Manzoni
Nov 7, 2019·Journal of Neurochemistry·Susanna CogoElisa Greggio
Sep 18, 2015·Science Translational Medicine·Marcel P van der BrugPatrick A Lewis
Dec 4, 2016·Biochemical Society Transactions·Giambattista GuaitoliChristian Johannes Gloeckner
Jan 26, 2017·Frontiers in Aging Neuroscience·Joseph M ThomasWanli W Smith
Sep 21, 2020·Bulletin of Mathematical Biology·Raina S RobevaLouis J Gross
Dec 9, 2016·Molecular Neurodegeneration·Dorien A Roosen, Mark R Cookson
Feb 17, 2017·Biochemical Society Transactions·Marian Blanca RamírezSabine Hilfiker
Jan 24, 2020·Frontiers in Neuroscience·Kirsten EbanksRina Bandopadhyay
Mar 4, 2020·Scientific Reports·Algerta MarkuGiovanni Piccoli
Jun 9, 2020·Frontiers in Neuroscience·Christian Johannes Gloeckner, Pablo Porras
Oct 11, 2016·Proteomics·Un-Beom Kang, Jarrod A Marto
Jan 25, 2020·Journal of Neurology·Susanne A Schneider, Roy N Alcalay
Jul 3, 2020·Frontiers in Neuroscience·Antoine MarchandJean-Marc Taymans
Dec 3, 2020·Nature Communications·Pablo PorrasSandra Orchard
Oct 30, 2020·Frontiers in Aging Neuroscience·Caroline L Benn, Lee A Dawson
Apr 30, 2021·Brain Research·Amrita VermaRina Bandopadhyay
May 23, 2021·Neurobiology of Disease·James E Tomkins, Claudia Manzoni

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
Affinity
Pull
Fluorescence
Pull Down
immunoprecipitation
protein array
Assay
Protein Kinase

Software Mentioned

TAB
eqnarray
WebGestalt
Cytoscape
MI
Panther
IntAct
Prism GraphPad
Excel
BioGRID

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.